Skip to main content

Table 2 Enriched KEGG pathways for the gene modules

From: Gene-microRNA network module analysis for ovarian cancer

No.

Enriched Pathways

p-value

17

Cytokine-cytokine receptor interaction

7.40E-05

 

NOD-like receptor signaling pathway

1.20E-03

 

Chemokine signaling pathway

5.80E-03

 

Hematopoietic cell lineage

3.30E-02

 

Complement and coagulation cascades

1.80E-01

 

Systemic lupus erythematosus

2.70E-01

18

p53 signaling pathway

3.50E-03

 

Small cell lung cancer

2.70E-03

 

Cell cycle

4.00E-03

 

Pathways in cancer

2.10E-02

 

Non-small cell lung cancer

8.20E-02

 

Glioma

8.00E-02

 

Melanoma

7.70E-02

 

Pancreatic cancer

6.90E-02

 

Chronic myeloid leukemia

6.40E-02

 

Prostate cancer

6.80E-02

24

Cytokine-cytokine receptor interaction

4.40E-05

 

NOD-like receptor signaling pathway

9.40E-04

 

Chemokine signaling pathway

4.30E-03

 

Hematopoietic cell lineage

2.70E-02

 

Complement and coagulation cascades

1.60E-01

 

Systemic lupus erythematosus

2.40E-01

28

Antigen processing and presentation

4.00E-03

 

Cytokine-cytokine receptor interaction

1.20E-02

 

Natural killer cell mediated cytotoxicity

9.20E-02

 

Hematopoietic cell lineage

1.30E-01

 

Graft-versus-host disease

1.70E-01

 

Chemokine signaling pathway

1.40E-01

 

NOD-like receptor signaling pathway

2.70E-01

 

Viral myocarditis

3.00E-01

31

Systemic lupus erythematosus

1.30E-02

41

Small cell lung cancer

1.30E-03

 

Chronic myeloid leukemia

3.10E-02

 

Pathways in cancer

2.40E-02

 

Colorectal cancer

1.90E-02

 

Cell cycle

3.40E-02

 

Thyroid cancer

1.30E-01

 

Bladder cancer

1.60E-01

 

Endometrial cancer

1.80E-01

 

Non-small cell lung cancer

1.60E-01

 

Acute myeloid leukemia

1.60E-01

 

Glioma

1.60E-01

 

p53 signaling pathway

1.50E-01

 

Melanoma

1.50E-01

 

Pancreatic cancer

1.40E-01

 

Prostate cancer

1.60E-01

43

ECM-receptor interaction

1.20E-09

 

Focal adhesion

6.70E-06

 

Vascular smooth muscle contraction

1.60E-01

21

Focal adhesion

8.80E-01

22

ECM-receptor interaction

8.30E-01

35

Acute myeloid leukemia

8.20E-01

 

p53 signaling pathway

6.40E-01

 

Chronic myeloid leukemia

5.20E-01

37

Hypertrophic cardiomyopathy (HCM)

7.00E-02

 

Gap junction

2.70E-01

 

Dilated cardiomyopathy

2.10E-01

 

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

4.60E-01

 

MAPK signaling pathway

7.80E-01

45

Pathways in cancer

7.30E-01

 

Basal cell carcinoma

5.00E-01

 

Hedgehog signaling pathway

3.70E-01